Last edited by Gardagor
Sunday, July 26, 2020 | History

2 edition of Bismuth salts in gastroenterology found in the catalog.

Bismuth salts in gastroenterology

Chukwuka Uchemefuna Nwokolo

Bismuth salts in gastroenterology

experiments in the absorption, distribution and disposal of bismuth in man

by Chukwuka Uchemefuna Nwokolo

  • 150 Want to read
  • 39 Currently reading

Published by University of Birmingham in Birmingham .
Written in English


Edition Notes

Thesis (M.D.) - University of Birmingham, Dept of Medicine.

Statementby Chukwuka Uchemefuna Nwokolo.
ID Numbers
Open LibraryOL20916076M

Bismuth subcitrate potassium is a salt of bismuth (Bi 3+), potassium (K +) and citrate (C 6 H 4 O 7 4−) in a molar ratio of about , with 3 moles of water. It contains about % (mass percent) bismuth, which is the active moiety, and % potassium. Other sources give somewhat different ratios of . Notably, most of the bismuth salts are inexpensive Lewis acid, non-toxic, and readily available reagents. In view of the rapidly expanding field of bismuth salts-mediated reactions and significant attention in this area from academic and industrial scientists, an issue of a journal on organobismuth mediated reactions would be necessary and timely.

Bismuth is a chemical element with the symbol Bi and atomic number It is a pentavalent post-transition metal and one of the pnictogens with chemical properties resembling its lighter group 15 siblings arsenic and tal bismuth may occur naturally, although its sulfide and oxide form important commercial ores. The free element is 86% as dense as lead. Background and Methods: The antibacterial activity of originally devised and synthesized organobismuth compounds was tested against fresh clinical isolates of Helicobacter pylori and compared with clinically well-established inorganic bismuth salts currently used in triple antibacterial treatment to eradicate H. test conditions in vitro were standard for determination of minimum.

Bismuth Salts for Gastrointestinal Issues 2 efficacy and safety of bismuth as part of BCQT in the treatment of H. pylori infection. Finally this report will retrieve and review the existing guidelines on the use of BCQT for H. pylori eradication treatment. Ford AC, Malfertheiner P, Giguere M, Santana J, Khan M, Moayyedi P. Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis. World Journal of Gastroenterology ; 14(48):


Share this book
You might also like
rise and decline of Jacksonian democracy.

rise and decline of Jacksonian democracy.

Swiss pension funds

Swiss pension funds

Il libro della poetica dAristotele

Il libro della poetica dAristotele

Financial resources for economic development

Financial resources for economic development

A token for youth, or Comfort to children

A token for youth, or Comfort to children

You and your Irish wolfhound

You and your Irish wolfhound

Wide-eyed in Babylon

Wide-eyed in Babylon

Three weeks to wed

Three weeks to wed

Decision at sea

Decision at sea

Bless the Beasts and the Children

Bless the Beasts and the Children

AlterNative

AlterNative

Revised potentiometric-surface map, Yucca Mountain and vicinity, Nevada

Revised potentiometric-surface map, Yucca Mountain and vicinity, Nevada

Prison catering

Prison catering

Bismuth salts in gastroenterology by Chukwuka Uchemefuna Nwokolo Download PDF EPUB FB2

GastroMycin caps with bismuth salts. This unique blend of bismuth salts, licorice, and plant-based supportive nutrients is updated with Oregon grape, neem, and cinnamon ulated blend.5/5(5). Sharon M. Gwaltney-Brant, in Haschek and Rousseaux's Handbook of Toxicologic Pathology (Third Edition), Sources and Exposure.

Bismuth salts, both organic and inorganic, have been used medicinally to treat a variety of infectious diseases, gastrointestinal disorders, and dermatological h-based radiocontrast media are used in diagnostic medicine.

Bismuth salts, including ranitidine bismuth citrate, colloidal bismuth subcitrate, and bismuth subnitrate appear to be safe when taken in doses of mg daily for up to 56 days. Recently published data showed that adding bismuth salts to a triple therapy of proton pump inhibitors, amoxicillin and clarithromycin helped eradicate Helicobacter pylori infection.

Javier P. Bismuth salts, including ranitidine bismuth citrate, colloidal bismuth subcitrate, and bismuth subnitrate appear to be safe when taken in doses of mg daily for up to 56 days. Bismuth is POSSIBLY UNSAFE when taken by mouth in large amounts due to the risk for kidney failure, and when taken over the long-term due to the risk of nerve damage.

Bismuth subsalicylate, sold as generic and under the brand name Pepto-Bismol, is an antacid elixir medication used to treat temporary discomforts of the stomach and gastrointestinal tract, such as nausea, heartburn, indigestion, upset stomach, and is also commonly known as pink bismuth, but Pepto-Bismol has become a genericized trademark for the substance.

INTRODUCTION. Bismuth salts have been used for centuries in medicine. From a gastroenterology perspective these drugs have been used to treat peptic ulcer disease, dyspepsia, parasitic infections, microscopic colitis, and infectious diarrhoea[].The discovery of Helicobacter pylori (H pylori) in by Warren and Marshall revolutionised the management of peptic ulcer disease[], and.

Amazon's Choice for bismuth CountlessBooks&More Bismuth Crystal Stone Medium Specimen for Collecting,Wire Wrapping,Wicca and Reiki Crystal Healing out of 5 stars Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy 1Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, and.

Bismuth Toxicity: A Rare Cause of Neurologic Dysfunction ratory’s ng/mL threshold for bismuth toxicity. Bis- muth levels in the urine were ng/mL, where a nor- mal value should be less than ng/mL.

Her bismuth subsalicylate was held, and over the next 2 days the patient became more alert, had decreased. Bismuth Salts for Gastrointestinal Issues: A Review of the Clinical Effectiveness and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; Nov Bismuth Salts for Gastrointestinal Issues: A Review of the Clinical Effectiveness and Guidelines [Internet].

A bismuth salt of salicylic acid. Little absorbed from the gastrointestinal tract, bismuth subsalicylate exerts a local effect on the gastric mucosa, coating it and protecting it from the corrosive effects of acid and pepsin. This agent also has local antimicrobial properties.

(NCI04) Definition (PDQ) A bismuth salt. SHERWOOD L. GORBACH GASTROENTEROLOGY Vol. 99, No. 3 bismuth oxychloride (BiOCl) and salicylic acid. Some intact BSS passes unchanged into the duodenum, where it can react with other anions such as bicarbon- ate and phosphate to form bismuth subcarbonate and bismuth phosphate salts.

The salicylate released from. Background & aims: Due to the poor eradication rates of standard triple therapy, the addition of bismuth salts has been proposed for first-line eradication of Helicobacter pylori.

We assessed the effectiveness and safety of the combination of bismuth and the standard, clarithromycin-containing triple therapy in eradication of H pylori infection, using data from a large multi-center registry.

Bismuth subsalicylate (BSS) has been used for more than 80 years to treat gastrointestinal symptoms although little clinical evidence was available until recently to substantiate its value and possible mechanisms of action. Abstract. Bismuth preparations are used for the treatment of various gastrointestinal disorders [1–3].

Various bismuth salts have recently become available for the treatment of Helicobacter pylori related gastroduodenal diseases [4–6]. Despite several beneficial effects of bismuth on the gastroduodenal mucosa, the antibacterial effect against H.

pylori appears the most important. [Association of bismuth salts and trisilicate of magnesium in gastroenterology] [Association of bismuth salts and trisilicate of magnesium in gastroenterology] Clinique (Paris).

Jun;47() [Article in Undetermined language] Author A COUSYN. PMID: No abstract available. Bismuth salts have been used for centuries in medi-cine. From a gastroenterology perspective these drugs have been used to treat peptic ulcer disease, dyspepsia, parasitic infections, microscopic colitis, and infectious diarrhoea[1].

The discovery of Helicobacter pylori (H pylori) in by Warren and Marshall revolutionised the man. The meta-analysis also included RCTs evaluating bismuth-based quadruple therapy as secondary treatment, which found cure rates averaging 78%.

1 The regimens varied, comprising bismuth salts ( mg, times daily), metronidazole ( mg, times daily), tetracycline ( mg, times daily), and a PPI (40 mg twice daily).

Longer duration of therapy produced higher cure rates. Bismuth subsalicylate (Pepto-Bismol) is the only colloidal bismuth salt drug approved for OTC use in multiple GI conditions, including “diarrhea, heartburn, indigestion without constipation, nausea, and upset stomach.” The mechanism of action of bismuth subsalicylate in these gastrointestinal disorders is not completely understood.

Bismuth There are two main types bismuth sibcitrate and bismuth subsalicylate. In the colon, bismuth salts reacts with hydrogen sulfide to form bismuth sulfide, which blackens the stools.

Adverse effects include bismuth intoxication; especially with chronic high dose use of bismuth subgallate. Coadministration of H2RAs increases bismuth absorption from bismuth sibcitrate, but not from bismuth.Get this from a library!

Bismuth salts for gastrointestinal issues: a review of the clinical effectiveness and guidelines. [Canadian Agency for Drugs and Technologies in Health,; Canadian Agency for Drugs and Technologies in Health.

Rapid Response Service.;] -- The purpose of this report is to retrieve and review existing evidence of clinical efficacy, safety, and guidelines for bismuth. DELHI: Combination of bismuth salts and triple therapy of proton pump inhibitors (PPIs), amoxicillin and clarithromycin helped in the eradication of Helicobacter pylori infection in more than 90% of the infected patients in a recent study published in the journal Clinical Gastroenterology and Hepatology.

A day standard triple therapy with clarithromycin and amoxicillin has a poor.